Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Image forming apparatus and job request control method instructed by authenticated users
Method for manufacturing thin film transistor and method for manufacturing display device
Method of making and using an alpha-glucanase composition to reduce or remove biofilm
Gas cap removal tool
Process of preparing functionalized polymers via enzymatic catalysis
Deposited conductive layers for leads of implantable electric stimulation systems and methods of making and using
  Randomly Featured Patents
Method and apparatus for lossless data transformation with preprocessing by adaptive compression, multidimensional prediction, multi-symbol decoding enhancement enhancements
Compliant electrical contacts
Formaldehyde-free insolubilizers for binders for paper coating compositions
Multistage condensing structure
Fuel supply misfire-detecting system for internal combustion engines
Automatic emergency locator system and method
Overlay join latency reduction using preferred peer list
Energy-efficient split-electrode TFEL panel
Exhaust gas treating tower
Method and a device for preparing brine